News
Chief reporter Neal Keeling had no idea what to expect when he started his cancer treatment - and was glad he didn't, but a ...
Welcome again, listeners. Now we're rounding out that month of July with Circulation on the Run in this nice July 29th issue. And I'm one of your co-hosts, Dr. Greg Hundley, associate editor and ...
8d
GlobalData on MSNMixed results from Roche’s mAb in COPDRoche’s IgG2 monoclonal antibody (mAb) astegolimab has yielded mixed results in chronic obstructive pulmonary disease (COPD), ...
Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...
Actor Mona Singh recently revealed her recipe for a natural and super nutritious protein powder, which involves dry fruits ...
The American Academy of Dermatology has updated its guidelines for treating and managing atopic dermatitis with topical and ...
Renal replacement therapy prolongs life in patients with Stage 5 chronic kidney disease. Сardiovascular diseases are the main ...
9d
News-Medical.Net on MSNAI reshapes ARDS care by predicting risk, guiding ventilation, and personalizing treatmentArtificial intelligence and machine learning are transforming acute respiratory distress syndrome (ARDS) management, enabling ...
One global clinical trial testing astegolimab for moderate to severe COPD hit its main goal, but another did not, Genentech ...
STUTTGART, Germany I July 21, 2025 I La Merie Publishing released its newest product entitled: TL1A Inhibitors & DR3 Antagonists: a Competitor Analysis ...
Plea deal suddenly ends Bryan Kohberger case. Do victims' families get a say? The resolution was reached over the objections of at least one of the victims' families.
In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results